- Published at
- by gurufocus.com
neutral
neutral
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2024 Revenue
Preliminary, unaudited revenue for the full year 2024 of approximately $174 million Presenting at the 43rd Annual J.P. Morgan Healthcare Conference on Thu